First-Ever Cannabis Periodic Table of Molecules™ Created by Acannability™
Acannability™ created the first-ever Cannabis Periodic Table of Molecules™ chart which reflects the original periodic table of elements.
In a recent press release (1), Acannability™ released the first-ever Cannabis Periodic Table of Molecules™ chart (2). The company is based in Chicago, Illinois and disclosed in their press release that they are “a member-driven, direct to consumer cooperative for the cannabis industry,” (1). In the company’s cannabis periodic table, it was meant to visually reflect the design of the periodic elements. It lists 51 cannabis molecules and precursor acids which have been categorized into four areas (1).
Acannability™’s Cannabis Periodic Table of Molecules™ chart was created via the review of over 400 molecules and the benefits associated with them that were detailed in published journals (1). The company hopes that this chart will help with education efforts in healthcare and also those interested in learning more about the industry. Scientific Advisor Joseph Friedman, RPh, MBA, a medical cannabis pharmacist and pharmacology expert, led the chart’s evolution (1).
"The Acannability™ table was developed to empower consumers with scientific facts of the plants ingredients," Friedman explained (1). "By utilizing this table, it is our hope that consumers will be able to make more informed purchasing decisions based on their needs and the products specific elements."
Shown in the Cannabis Periodic Table of Molecules™ there are four categories: cannabinoids, flavonoids, terpenes, cannabinoids, and 6 precursor acids which are displayed underneath the other molecule sections (1,2). The chart contains a total of 51 boxes with the molecules being listed from left to right and go by increasing atomic weight (1).
Acannability™ wishes that their periodic table will be utilized to inspire conversation regarding the plant’s benefits, as well as, education, selection of products, and industry trends (1). The goal is to encourage cannabis consumers to use their education and knowledge to help them figure out what cannabis products would be best for them to purchase (1).
Acannability™’s Cannabis Periodic Table of Molecules™ chart is accessible to Acannability members and is also offered at no cost to the cannabis community via a copyright license acknowlesgement (1). For a printable version of the chart, please can visit their website: https://acannability.com (3).
References
- Acannability. AcannabilityTM Launches First Periodic Table of Cannabis Molecules Aimed at Mutual Education Between Consumer and Industry Leaders https://www.prnewswire.com/news-releases/acannability-launches-first-periodic-table-of-cannabis-molecules-aimed-at-mutual-education-between-consumer-and-industry-leaders-301998657.html#:~:text=%22The%20AcannabilityTM%20table%20was,and%20the%20products%20specific%20elements.%22 (accessed Nov 28, 2023).
- Acannability. Cannabis Periodic Table of Molecules https://acannability.com/periodictable/ (accessed Nov 28, 2023).
- Acannability. https://acannability.com/ (accessed Nov 28, 2023).
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
